Eculizumab-induced late erythroid maturation arrest: a case report

Br J Haematol. 2020 Oct;191(1):120-122. doi: 10.1111/bjh.16936. Epub 2020 Jul 15.

Authors

Joshua Dower¹, Danai Dima¹, Jakob Sieker², Monika Pilichowska², Cindy Varga³

Affiliations

¹ Department of Medicine, Tufts Medical Center, Boston, MA, USA.
² Division of Pathology, Tufts Medical Center, Boston, MA, USA.
³ Division of Hematology-Oncology, Tufts Medical Center, The John Conant Davis Myeloma and Amyloid Program, Boston, MA, USA.

PMID: 32671821
DOI: 10.1111/bjh.16936

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / administration & dosage
Antibodies, Monoclonal, Humanized* / adverse effects
Erythroid Cells*
Female
Humans
Kidney Failure, Chronic / therapy*
Kidney Transplantation*
Middle Aged
Polycystic Kidney Diseases / therapy*
Thrombocytopenia* / blood
Thrombocytopenia* / drug therapy
Thrombocytopenia* / etiology

Substances

Antibodies, Monoclonal, Humanized
eculizumab